NASDAQ:MEDS - Nasdaq - US89846A4058 - Common Stock - Currency: USD
Taking everything into account, MEDS scores 3 out of 10 in our fundamental rating. MEDS was compared to 37 industry peers in the Health Care Technology industry. The financial health of MEDS is average, but there are quite some concerns on its profitability. MEDS is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 28.09% | ||
ROE | 35.39% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 94.17% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -2.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.18 | ||
Quick Ratio | 4.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 125.16% |
7.59
+0.35 (+4.83%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 125.16% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 2.5 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.94 | ||
P/tB | 0.94 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 28.09% | ||
ROE | 35.39% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 94.17% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.18 | ||
Quick Ratio | 4.18 | ||
Altman-Z | -2.4 |